나고야-쿠알라룸푸르 추가의정서의 성립과정과 향후과제 -유전자변형생물체(LMO)의 환경방출사례를 중심으로- (A Study on the Establishing Process and Tasks of Nagoya-Kualalumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety -Focused on the Case of LMO's Release into En)

서지정보

· 발행기관 : 한남대학교 과학기술법연구원
· 수록지 정보 : 과학기술법연구 / 17권 / 2호 / 3 ~ 45페이지
· 저자명 : 박기주

초록

On 16 October 2010, a new international treaty, the Nagoya–Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety, was adopted at one of the largest intergovernmental meetings ever held on the safe use of modern biotechnology. The adoption of the new treaty was generated from the end of the five-day meeting of the governing body of the Cartagena Protocol on Biosafety (known as the Conference of the Parties serving as the meeting of the Parties to the Protocol or COP-MOP 5) and concluded six years of negotiations. The new supplementary Protocol provides international rules and procedure on liability and redress for damage to biodiversity resulting from living modified organisms (LMO).


The term "liability" is normally related with the obligation under the applicable law to provide for compensation for damage resulting from an action for which that person is deemed to be responsible. Liability and redress in the context of the Protocol concerns the question of what would happen if the transboundary movement of living modified organisms (LMOs) has caused damage. The issue of liability and redress for damage resulting from the transboundary movements of LMOs was one of the themes on the agenda during the negotiation of the Biosafety Protocol. The negotiators were, however, unable to reach any consensus regarding the details of a liability regime under the Protocol. The matter was, nevertheless, considered both critical and urgent. As a result, an enabling clause to that effect was included in the final text of the Protocol.


The Protocol itself is not perfect for parties to lead their legislation. There are many problems to legislate this Protocol as new act for LMO's damage. In this regard, legislator should focus on the purpose of this Protocol and deliberate its workable legal mechanism. Legislator should study distinctive features of LMO in legislation process and adopt effective civil procedure, civil liability system, buren of proving and financial security. It is anticipated that we will have amounts of obstacles in legislating this Protocol as effective and workable act for LMO's damage. However, legislator should endeavor to establish and develop this Protocol as enforcing act for the safe use of LMO and the development of modern biotechnology.

영어초록

On 16 October 2010, a new international treaty, the Nagoya–Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety, was adopted at one of the largest intergovernmental meetings ever held on the safe use of modern biotechnology. The adoption of the new treaty was generated from the end of the five-day meeting of the governing body of the Cartagena Protocol on Biosafety (known as the Conference of the Parties serving as the meeting of the Parties to the Protocol or COP-MOP 5) and concluded six years of negotiations. The new supplementary Protocol provides international rules and procedure on liability and redress for damage to biodiversity resulting from living modified organisms (LMO).


The term "liability" is normally related with the obligation under the applicable law to provide for compensation for damage resulting from an action for which that person is deemed to be responsible. Liability and redress in the context of the Protocol concerns the question of what would happen if the transboundary movement of living modified organisms (LMOs) has caused damage. The issue of liability and redress for damage resulting from the transboundary movements of LMOs was one of the themes on the agenda during the negotiation of the Biosafety Protocol. The negotiators were, however, unable to reach any consensus regarding the details of a liability regime under the Protocol. The matter was, nevertheless, considered both critical and urgent. As a result, an enabling clause to that effect was included in the final text of the Protocol.


The Protocol itself is not perfect for parties to lead their legislation. There are many problems to legislate this Protocol as new act for LMO's damage. In this regard, legislator should focus on the purpose of this Protocol and deliberate its workable legal mechanism. Legislator should study distinctive features of LMO in legislation process and adopt effective civil procedure, civil liability system, buren of proving and financial security. It is anticipated that we will have amounts of obstacles in legislating this Protocol as effective and workable act for LMO's damage. However, legislator should endeavor to establish and develop this Protocol as enforcing act for the safe use of LMO and the development of modern biotechnology.

참고자료

· 없음